BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home » Topics » Articles » Insight

Insight
Insight RSS Feed RSS

Grants, Contracts And Awards To Biotech Companies:Oct. 17, 2003 - March 31, 2004

April 5, 2004

Chiron Scraps Matrix Drug; Diversified Dream Still Alive

March 29, 2004
By Randy Osborne
In Greek mythology, Chiron was a centaur associated with healing - not a bad figure for a biotechnology firm to hook itself up with. But in the industry, what is Chiron Corp. known for? Quickly, now.
Read More

Money Raised Year To Date

March 29, 2004

Stock Winners and Losers For The Week

March 29, 2004

Biotech Mergers And Acquisitions: Dec. 18, 2003 - March 18, 2004#

March 29, 2004

BioWorld Stock Report For Public Biotechnology Companies

March 29, 2004

Stock Winners and Losers For The Week

March 22, 2004

Collaborations Between Biotechnology Companies And Universities/Nonprofit Institutions: Nov. 25, 2003 - March 18, 2004

March 22, 2004

BioWorld Stock Report For Public Biotechnology Companies

March 22, 2004

Cool 'TLRs Growing Hot' In Biotech; Coley Out In Front

March 22, 2004
By Randy Osborne
"Toll-like receptor" sounds like a cop waiting at a highway coin basket to catch those who pass through without paying. And, in a way, that's what toll-like receptors, or TLRs, are. (BioWorld Financial Watch)
Read More
Previous 1 2 … 932 933 934 935 936 937 938 939 940 … 1088 1089 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 2, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 2, 2026
  • Pancreas 3D hologram

    ASCO 2026: A revolution in pancreatic cancer

    BioWorld
    At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
  • Healthy (left) vs. cancerous bone marrow

    BMS’ mezigdomide doubles PFS in multiple myeloma

    BioWorld
    Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
  • Antibodies attacking cancer cell

    ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal

    BioWorld
    Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing